Erminia Rinaldi

573 total citations
9 papers, 338 citations indexed

About

Erminia Rinaldi is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Erminia Rinaldi has authored 9 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 5 papers in Genetics and 4 papers in Oncology. Recurrent topics in Erminia Rinaldi's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Bone health and treatments (3 papers) and Complement system in diseases (3 papers). Erminia Rinaldi is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Bone health and treatments (3 papers) and Complement system in diseases (3 papers). Erminia Rinaldi collaborates with scholars based in Italy. Erminia Rinaldi's co-authors include Giorgina Specchia, Paola Curci, Rita Rizzi, Vincenzo Liso, Alberta Zallone, Giacomina Brunetti, Maria Grano, Angela Oranger, Giorgio Mori and Silvia Colucci and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and Thrombosis and Haemostasis.

In The Last Decade

Erminia Rinaldi

9 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Erminia Rinaldi Italy	5	194	139	98	77	73	9	338
Talha Badar United States	14	161 0.8×	390 2.8×	222 2.3×	192 2.5×	84 1.2×	106	642
Xiu Yan Xie United States	6	59 0.3×	189 1.4×	56 0.6×	105 1.4×	67 0.9×	9	312
Grant R. Goodman United States	12	236 1.2×	54 0.4×	130 1.3×	246 3.2×	161 2.2×	16	552
JM Hernández Spain	8	115 0.6×	346 2.5×	187 1.9×	100 1.3×	54 0.7×	12	426
Caner Saygin United States	11	174 0.9×	150 1.1×	104 1.1×	63 0.8×	108 1.5×	29	449
G. Mahl Israel	7	124 0.6×	304 2.2×	89 0.9×	240 3.1×	88 1.2×	8	412
Anna Mansour France	8	155 0.8×	154 1.1×	266 2.7×	86 1.1×	9 0.1×	10	485
Ashley A. Basiorka United States	9	68 0.4×	368 2.6×	246 2.5×	149 1.9×	23 0.3×	20	611
Kaoru Hatano Japan	10	107 0.6×	263 1.9×	141 1.4×	61 0.8×	45 0.6×	37	389
Lixun Guan China	9	58 0.3×	140 1.0×	121 1.2×	140 1.8×	42 0.6×	33	341

Countries citing papers authored by Erminia Rinaldi

Since Specialization

Citations

This map shows the geographic impact of Erminia Rinaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erminia Rinaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erminia Rinaldi more than expected).

Fields of papers citing papers by Erminia Rinaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erminia Rinaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erminia Rinaldi. The network helps show where Erminia Rinaldi may publish in the future.

Co-authorship network of co-authors of Erminia Rinaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Erminia Rinaldi. A scholar is included among the top collaborators of Erminia Rinaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erminia Rinaldi. Erminia Rinaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Agosti, Pasquale, Pasqualina De Leo, Marco Capecchi, et al.. (2023). Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry. Research and Practice in Thrombosis and Haemostasis. 7(6). 102185–102185. 4 indexed citations

2.

Rinaldi, Erminia, et al.. (2019). PB1748 DECITABINE AS S‐AML TREATMENT FOLLOWING AZACYTIDINE FAILURE: A SINGLE CENTER EXPERIENCE. HemaSphere. 3(S1). 803–804. 1 indexed citations

3.

Valsecchi, Carla, Maribel Mirabet, Ilaria Mancini, et al.. (2019). Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity. Thrombosis and Haemostasis. 119(11). 1767–1772. 41 indexed citations

4.

Mancini, Ilaria, Silvia Pontiggia, Barbara Ferrari, et al.. (2016). Natural History of Patients Affected with Thrombotic Thrombocytopenic Purpura: Milan TTP Registry. Blood. 128(22). 3731–3731. 1 indexed citations

5.

Brunetti, Giacomina, Angela Oranger, Giorgio Mori, et al.. (2011). Sclerostin is overexpressed by plasma cells from multiple myeloma patients. Annals of the New York Academy of Sciences. 1237(1). 19–23. 69 indexed citations

6.

Colucci, Silvia, Giacomina Brunetti, Angela Oranger, et al.. (2011). Myeloma cells suppress osteoblasts through sclerostin secretion. Blood Cancer Journal. 1(6). e27–e27. 104 indexed citations

7.

Colucci, Silvia, Giacomina Brunetti, Angela Oranger, et al.. (2010). Myeloma Cells Induce Osteoblast Suppression through Sclerostin Secretion. Blood. 116(21). 2961–2961. 4 indexed citations

8.

Rizzi, Rita, Paola Curci, Mario Delia, et al.. (2008). Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Medical Oncology. 26(1). 1–9. 100 indexed citations

9.

Rizzi, Rita, Paola Curci, Erminia Rinaldi, et al.. (2008). Schnitzler’s Syndrome: Monoclonal Gammopathy Associated with Chronic Urticaria. Acta Haematologica. 120(1). 1–4. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact